![Paul van der Horst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul van der Horst
Président chez
MOLECURE S.A.
Fortune : - $ au 31/05/2026
Profil
Currently, Paul van der Horst is Chairman of the Supervisory Board at Molecure SA since 2023, Director at Immunetune, and Chief Business Officer at AgomAb Therapeutics NV since 2024.
Formerly, Mr. van der Horst was Director of Business Development at Galapagos NV from 2019 to 2021, Non-Executive Director at Fibrocor Therapeutics, Inc. from 2020 to 2021, and Analyst at Van Lanschot Kempen NV (Broker).
Education includes a doctorate from Erasmus University Rotterdam.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Paul van der Horst
| Sociétés | Poste | Début |
|---|---|---|
| MOLECURE S.A. | Président | 01/06/2023 |
| AGOMAB THERAPEUTICS NV | Corporate Officer/Principal | 01/11/2024 |
Immunetune
 Immunetune BiotechnologyHealth Technology Develops next-generation DNA vaccines against cancer and infectious diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul van der Horst
| Sociétés | Poste | Fin |
|---|---|---|
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Directeur/Membre du Conseil | 01/04/2021 |
| LAKEFRONT BIOTHERAPEUTICS NV | Public Communications Contact | 01/04/2019 |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Formation de Paul van der Horst
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Molecure SA
 Molecure SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs used in the treatment of inflammatory & cancer diseases | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Health Technology |
Immunetune
Immunetune BiotechnologyHealth Technology Develops next-generation DNA vaccines against cancer and infectious diseases | Health Technology |
